DiaMedica Therapeutics In...

NASDAQ: DMAC · Real-Time Price · USD
6.03
0.02 (0.33%)
At close: Aug 15, 2025, 3:59 PM
6.03
0.08%
After-hours: Aug 15, 2025, 04:10 PM EDT

DiaMedica Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-29.58M -27M -24.44M -21.7M -19.9M -19.26M -19.38M -17.97M -16.56M -15.44M -13.68M -13.17M -13.56M -13.48M -13.59M -14.55M -14.29M -13.49M
Depreciation & Amortization
-145K 42K 39K 36K 34K 31K 30K 28K 27K 26K 25K 25K 24K 24K 24K 23K 22K 21K
Stock-Based Compensation
2.79M 2.46M 2.08M 1.95M 1.81M 1.75M 1.68M 1.64M 1.63M 1.62M 1.5M 1.39M 1.27M 1.35M 1.56M 1.77M 1.97M 1.96M
Other Working Capital
1.79M 2.18M 1.36M 1.24M -178.32K -380.32K 20.68K -440K -21K 29K 360K -209K -661K 252K 129K 25.82M 55.88M 65.9M
Other Non-Cash Items
-1.39M -1.2M -1.27M -611.03K -247.03K 69.97K 192.97K -265K -309K -270K 53K 180K 221K 179K 58K 56K 54K 53K
Deferred Income Tax
n/a n/a n/a -466.72K -890.72K -1.12M -1.12M -651K -227K n/a n/a 110K 123K 135K 161K 71K 57K 36K
Change in Working Capital
2.67M 3.12M 1.51M 1.57M -355.04K -1.53M 96.96K -461K 191K 1.36M 585K -82K -314K -42K -461K 166K 420K 898K
Operating Cash Flow
-25.65M -22.57M -22.08M -19.22M -19.55M -20.06M -18.5M -17.68M -15.25M -12.71M -11.51M -11.55M -12.23M -11.83M -12.25M -12.46M -11.77M -10.52M
Capital Expenditures
-34K -27.93K -24.93K -20.63K -21.63K -25.69K -23.69K -53K -86K -88K -81K -56K -15K -13K -22K -60K -58K -54K
Cash Acquisitions
n/a n/a n/a -24.4K -25.61K 2.52K n/a 19.65K 18.74K -11.92K -9.4K -4.65K -2.58K -10.9 1.99K 1.99K 2.03K 2K
Purchase of Investments
-48.73M -47.49M -50.41M -43.6M -33.81M -68.47M -68.51M -74.33M -70.92M -42.13M -45.68M -57.97M -72.08M -71.27M -69.81M -62.44M -56.19M -42.87M
Sales Maturities Of Investments
63.97M 58.5M 59M 53.37M 50.37M 52.16M 50.5M 54.68M 52.18M 54.05M 57.3M 56.15M 55.32M 52.97M 49.3M 51.3M 43.88M 32.06M
Other Investing Acitivies
-439 -439 -439 24.4K 25.61K -2.52K n/a -19.65K -18.74K 11.92K 11.62K -1.82K -16.76K -18.3K -18.52K 6.17K 4.99K 6.5K
Investing Cash Flow
15.2M 10.98M 8.56M 9.75M 16.53M -16.33M -18.03M -19.7M -18.82M 11.83M 11.54M -1.88M -16.77M -18.31M -20.54M -11.18M -12.35M -10.84M
Debt Repayment
-9K -11K -9K -6.92K -5.92K -5.92K -5.92K -5.84K -5.77K -5.75K -5.75K -4.91K -4.99K -3K -4K -5K -4K -4K
Common Stock Repurchased
n/a n/a n/a n/a -4K 205M 205M 205M 205M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
322.29K 244.47K 244.47K 46.29K 83.18K 36.85M 36.85M 36.85M 36.85M -246.43 -246.43 -1.09K -1.01K -2K 242K 205K 205K 205K
Financial Cash Flow
495K 12.09M 11.99M 11.38M 11.26M 36.35M 36.35M 36.84M 36.85M -6K -6K -5.02K 26.85K 28.85K 30.09K -8.89K 21.15M 21.15M
Net Cash Flow
-9.96M 492K -1.52M 1.9M 8.23M -50K -185K -539K 2.78M -885K 21K -13.45M 834K -297K -2.7M 6.42M -2.73M 29K
Free Cash Flow
-25.68M -22.6M -22.1M -19.24M -19.57M -20.09M -18.52M -17.73M -15.33M -12.8M -11.59M -11.61M -12.25M -11.84M -12.27M -12.52M -11.82M -10.57M